ADXN

Addex Therapeutics Ltd

PHARMACEUTICAL PREPARATIONS
LIFE SCIENCES

Prices are adjusted according to historical splits.

Addex Therapeutics Ltd Stock Price

Vitals

Today's Low:
$0.7701
Today's High:
$0.8396
Open Price:
$0.8080
52W Low:
$0.642
52W High:
$8.38
Prev. Close:
$0.8000
Volume:
72172

Company Statistics

Market Cap.:
$0.007 billion
Book Value:
1.086
Revenue TTM:
$0.002 billion
Operating Margin TTM:
-1303%
Gross Profit TTM:
$-0.010 billion
Gross Profit TTM:
$-0.010 billion
Profit Margin:
0%
Return on Assets TTM:
-78.6%
Return on Equity TTM:
-181%

Company Profile

Addex Therapeutics Ltd had its IPO on 2020-01-29 under the ticker symbol ADXN.

The company operates in the LIFE SCIENCES sector and PHARMACEUTICAL PREPARATIONS industry. Addex Therapeutics Ltd has a staff strength of 0 employees.

Stock update

Shares of Addex Therapeutics Ltd opened at $0.81 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $0.77 - $0.84, and closed at $0.83.

This is a +3.75% increase from the previous day's closing price.

A total volume of 72,172 shares were traded at the close of the day’s session.

In the last one week, shares of Addex Therapeutics Ltd have slipped by -17%.

Addex Therapeutics Ltd's Key Ratios

Addex Therapeutics Ltd has a market cap of $0.007 billion, indicating a price to book ratio of 1.06 and a price to sales ratio of 4.325.

In the last 12-months Addex Therapeutics Ltd’s revenue was $0.002 billion with a gross profit of $-0.010 billion and an EBITDA of $-0.021 billion. The EBITDA ratio measures Addex Therapeutics Ltd's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Addex Therapeutics Ltd’s operating margin was -1303% while its return on assets stood at -78.6% with a return of equity of -181%.

In Q2, Addex Therapeutics Ltd’s quarterly earnings growth was a positive 0% while revenue growth was a negative 82.6%.

Addex Therapeutics Ltd’s PE and PEG Ratio

Forward PE
-
Trailing PE
-
PEG
None

Its diluted EPS in the last 12-months stands at $-3.264 per share while it has a forward price to earnings multiple of - and a PEG multiple of None. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Addex Therapeutics Ltd’s profitability.

Addex Therapeutics Ltd stock is trading at a EV to sales ratio of 0.196 and a EV to EBITDA ratio of 0.0542. Its price to sales ratio in the trailing 12-months stood at 4.325.

Addex Therapeutics Ltd stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$0.000 billion
Total Liabilities
$0.000 billion
Operating Cash Flow
$0.000 billion
Capital Expenditure
$0.000 billion
Dividend Payout Ratio
0%

Addex Therapeutics Ltd ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Addex Therapeutics Ltd ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Addex Therapeutics Ltd’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Addex Therapeutics Ltd's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Addex Therapeutics Ltd paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price
$0.83
52-Week High
$8.38
52-Week Low
$0.642
Analyst Target Price
$None

Addex Therapeutics Ltd stock is currently trading at $0.83 per share. It touched a 52-week high of $8.38 and a 52-week low of $8.38. Analysts tracking the stock have a 12-month average target price of $None.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Addex Therapeutics Ltd

The stock symbol (also called stock or share ticker) of Addex Therapeutics Ltd is ADXN

The IPO of Addex Therapeutics Ltd took place on 2020-01-29

Similar Industry Stocks (PHARMACEUTICAL PREPARATIONS)

Last Price
Chg
Chg%
$0.13
-0
-2.26%
$3.4
0.06
+1.8%
$0.56
-0.01
-1.03%
$6.37
-0.14
-2.15%
$50.5
1.63
+3.34%

Most Active

Last Price
Chg
Chg%
$58.63
-1.03
-1.73%
$92.12
-4.67
-4.82%
$5.12
-0.61
-10.65%
Apple Inc (AAPL)
$145.03
-5.62
-3.73%
$0.06
0.01
+12.74%

Top Gainers

Last Price
Chg
Chg%
$73
42.7
+140.92%
Oi S.A (OIBR-C)
$0
0
+100%
$0.02
0.01
+100%
$0.25
0.1
+66.44%
$2.85
1.01
+54.86%

Top Losers

Last Price
Chg
Chg%
$5.36
-22.58
-80.82%
$0.02
-0.06
-78.67%
Air T, Inc (AIRTW)
$0.01
-0.03
-75%
$4.51
-5.17
-53.41%
$11.5
-12.2
-51.48%

About

Addex Therapeutics Ltd, a developing-stage biopharmaceutical company, discovers, develops and markets small molecule pharmaceuticals for central nervous system (CNS) disorders in Switzerland. The company is headquartered in Geneva, Switzerland.

Address

CHEMIN DES MINES 9, GENEVA, SWITZERLAND